Cargando…

A Peptidylic Inhibitor for Neutralizing (r)(GGGGCC)(exp)-Associated Neurodegeneration in C9ALS-FTD

One drug, two diseases is a rare and economical therapeutic strategy that is highly desirable in the pharmaceutical industry. We previously reported a 21-amino acid peptide named beta-structured inhibitor for neurodegenerative diseases (BIND) that can effectively inhibit expanded CAG trinucleotide t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qian, An, Ying, Chen, Zhefan Stephen, Koon, Alex Chun, Lau, Kwok-Fai, Ngo, Jacky Chi Ki, Chan, Ho Yin Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424097/ https://www.ncbi.nlm.nih.gov/pubmed/30889483 http://dx.doi.org/10.1016/j.omtn.2019.02.015

Ejemplares similares

A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases
por: Zhang, Qian, et al.
Publicado: (2018)

The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD
por: He, Fang, et al.
Publicado: (2020)

Crystal structure of parallel G-quadruplex formed by the two-repeat ALS- and FTD-related GGGGCC sequence
por: Geng, Yanyan, et al.
Publicado: (2021)

Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence
por: Zhou, Bo, et al.
Publicado: (2018)

Solution structure of a DNA quadruplex containing ALS and FTD related GGGGCC repeat stabilized by 8-bromodeoxyguanosine substitution
por: Brčić, Jasna, et al.
Publicado: (2015)

Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila
por: Zhang, Qian, et al.
Publicado: (2016)

Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD.
por: Goodman, Lindsey D., et al.
Publicado: (2019)

FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD
por: Fujino, Yuzo, et al.
Publicado: (2023)

Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD
por: Yuva-Aydemir, Yeliz, et al.
Publicado: (2019)

A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K, et al.
Publicado: (2014)

GULP1/CED-6 ameliorates amyloid-β toxicity in a Drosophila model of Alzheimer’s disease
por: Vivien Chiu, Wai Yin, et al.
Publicado: (2017)

Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K., et al.
Publicado: (2016)

RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
por: Ramesh, Nandini, et al.
Publicado: (2020)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

Editorial: Current Concept and Translational Study in ALS–FTD Spectrum: From Genetics, Neuroinflammation to Neurodegeneration
por: Guo, Wenting, et al.
Publicado: (2022)

Molecular insights into the interaction of CAG trinucleotide RNA repeats with nucleolin and its implication in polyglutamine diseases
por: An, Ying, et al.
Publicado: (2022)

Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology
por: Diab, Rim, et al.
Publicado: (2023)

Inflammation in ALS/FTD pathogenesis
por: McCauley, Madelyn E., et al.
Publicado: (2018)

DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication
por: Wang, Haibo, et al.
Publicado: (2021)

The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
por: Masrori, Pegah, et al.
Publicado: (2022)

Erratum: Autophagy and neurodegeneration: unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology
Publicado: (2023)

Cognitive and behavioral features of c9FTD/ALS
por: Boeve, Bradley F, et al.
Publicado: (2012)

A blood–brain penetrant RNA-targeted small molecule triggers elimination of r(G(4)C(2))(exp) in c9ALS/FTD via the nuclear RNA exosome
por: Bush, Jessica A., et al.
Publicado: (2022)

The Peptidyl-prolyl Isomerase Pin1 in Neuronal Signaling: from Neurodevelopment to Neurodegeneration
por: Fagiani, Francesca, et al.
Publicado: (2020)

Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
por: Fratta, Pietro, et al.
Publicado: (2013)

DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene
por: Thys, Ryan Griffin, et al.
Publicado: (2015)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Motor Neuron Susceptibility in ALS/FTD
por: Ragagnin, Audrey M. G., et al.
Publicado: (2019)

Graph theory network analysis provides brain MRI evidence of a partial continuum of neurodegeneration in patients with UMN-predominant ALS and ALS-FTD
por: Rajagopalan, Venkateswaran, et al.
Publicado: (2022)

ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
por: Stoica, Radu, et al.
Publicado: (2014)

The era of cryptic exons: implications for ALS-FTD
por: Mehta, Puja R., et al.
Publicado: (2023)

CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration
por: Krishnan, Gopinath, et al.
Publicado: (2020)

Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum
por: Devenney, Emma M., et al.
Publicado: (2021)

Emerging roles of the neural adaptor FE65 in neurite outgrowth
por: Li, Wen, et al.
Publicado: (2018)

The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD
por: Freibaum, Brian D., et al.
Publicado: (2017)

Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
por: Mayl, Keith, et al.
Publicado: (2021)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
por: Ghaffari, Layla T., et al.
Publicado: (2022)

Linking hnRNP Function to ALS and FTD Pathology
por: Purice, Maria D., et al.
Publicado: (2018)

Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
por: Godoy-Corchuelo, Juan Miguel, et al.
Publicado: (2022)

ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion
por: Henderson, Robert David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oc51fb2rq9vn8uq0l2vbiph254